Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, January 6, 2026.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Strong Uptrend (+100) - REGN is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, REGN continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid REGN?
MarketClub looks at technical strength and momentum to determine if the timing is right for REGN.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for REGN
The long-term trend has been UP since Oct 1st, 2025 at 610.45
The intermediate-term trend has been UP since Dec 22nd, 2025 at 779.92
The short-term trend has been UP since Jan 6th, 2026 at 779.75
Smart Scan Analysis for REGN
Based on our trend formula, REGN is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 764.350 | 787.656 | 763.195 | 776.450 | +13.220 |
| Prev. Close | Volume | Bid | Ask | Time |
| 763.230 | 758813 | 2026-01-06 15:59:45 |
| Year High | 416.49 | Year High Date | 2018-08-30 |
| Year Low | 281.89 | Year Low Date | 2018-05-09 |
| 52wk High | 792.77 | 52wk High Date | 2025-12-24 |
| 52wk Low | 476.4869 | 52wk Low Date | 2025-06-05 |
| Year End Close | 171.07 | Average Volume | 815,560 |
| Shares Outstanding | 105,099 | Short Interest | 4,273,307 |
| % Institutional | 93.5 | Market Cap | 31,118M |
| Assets | 401,694,000M | Liabilities | 921,160,000M |
| P/E Ratio | 18.2547 | Beta | 0.77 |
| Volatility | 37.15 |